跳至主要内容
临床试验/JPRN-jRCTs061180061
JPRN-jRCTs061180061已完成2 期

Inhibitory effects of dietary glucosylceramides on head and neck squamous cell carcinoma carcinogenesis and metastasis

Fujiwara Kazunori0 个研究点目标入组 6 人开始时间: 2019年3月18日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
6

研究概览

简要总结

Due to the small number of cases, it is not possible to concluded that it has the potential to improve prognosis for head and neck cancer. Since it is an extract from a food, no obvious adverse events are expected.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1)Histological type is squamous cell carcinoma
  • 2)Primary site is paranasal sinus, oral cavity, oropharynx, hypopharynx, larynx.
  • 3)Stage3 or stage4A,4B, which had surgery, radiation and chemoradiation.
  • 4)Cases identified as complete response by histological examination and imaging test.
  • 5)20 years of age and older.
  • 6)Ability of oral intake
  • 7)Performance status (PS) 0-1
  • 8)No abnormalities of Bone marrow function, renal function, and liver function within the first 14 days.
  • 9)Informed concent is obtained.

排除标准

  • 1)Cases with allergic symptom by konnyaku.
  • 2)Cases with infection disease requiring treatment
  • 3)Cases with gastrointestinal disease requiring treatment
  • 4)Cased with interstitial pneumonia and lung fibrosis.
  • 5)Cases with poorly controlled diabetes.
  • 6)Cases with severe liver damage.
  • 7)Cases with severe diarrhea.
  • 8)Pregnant woman or potential.
  • 9)Cases deemed inappropriate by principal investigator.

研究者

发起方
Fujiwara Kazunori

相似试验